Axsome Therapeutics (AXSM)
(Delayed Data from NSDQ)
$86.53 USD
+0.55 (0.64%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $86.49 -0.04 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/5/24 |
---|---|
Current Quarter | -1.30 |
EPS Last Quarter | -1.09 |
Last EPS Surprise | 9.17% |
ABR | 1.24 |
Earnings ESP
|
-3.65% |
---|---|
Current Year | -4.93 |
Next Year | -0.13 |
EPS (TTM) | -4.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 84.53M | 95.20M | 364.22M | 640.41M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 87.20M | 101.40M | 384.70M | 738.14M |
Low Estimate | 81.00M | 91.00M | 351.80M | 467.71M |
Year ago Sales | 46.70M | 57.79M | 270.60M | 364.22M |
Year over Year Growth Est. | 81.01% | 64.74% | 34.60% | 75.83% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.30 | -1.12 | -4.93 | -0.13 |
# of Estimates | 9 | 7 | 10 | 10 |
Most Recent Consensus | -1.41 | -1.21 | -5.38 | -2.85 |
High Estimate | -0.91 | -0.75 | -3.62 | 3.53 |
Low Estimate | -1.67 | -1.37 | -6.36 | -3.91 |
Year ago EPS | -1.00 | -1.32 | -2.67 | -4.93 |
Year over Year Growth Est. | -30.00% | 15.15% | -84.64% | 97.46% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 3 | 1 | 3 | 3 |
Up Last 60 Days | 3 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 0 | 1 | 2 | 0 |
Down Last 60 Days | 0 | 1 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.30 | -1.12 | -4.93 | -0.13 |
7 Days Ago | -1.30 | -1.13 | -4.92 | -0.18 |
30 Days Ago | -1.32 | -1.12 | -4.93 | -0.23 |
60 Days Ago | -1.32 | -1.12 | -4.93 | -0.23 |
90 Days Ago | -1.07 | -0.86 | -3.86 | 0.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.35 | -1.29 | -5.46 | -1.93 |
Zacks Consensus Estimate | -1.30 | -1.12 | -4.93 | -0.13 |
Earnings ESP | -3.65% | -15.04% | -10.81% | -1,434.37% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.09 | -0.73 | -1.32 | -1.00 | NA |
Estimate | -1.20 | -1.21 | -1.24 | -1.24 | NA |
Difference | 0.11 | 0.48 | -0.08 | 0.24 | 0.19 |
Surprise | 9.17% | 39.67% | -6.45% | 19.35% | 15.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more